Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.57
-0.09 (-1.59%)
Nov 16, 2026, 4:00 PM EST - Market closed

Myriad Genetics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
107.1149.6102.4132.156.9257.4
Short-Term Investments
---8.85881.4
Cash & Short-Term Investments
107.1149.6102.4140.9114.9338.8
Cash Growth
-26.34%46.09%-27.32%22.63%-66.09%124.82%
Accounts Receivable
105.5115.3121.2114.3101.691.3
Receivables
105.5115.3121.2114.3101.691.3
Inventory
28.630.627.52220.115.3
Prepaid Expenses
30.735.437.435.23639.4
Restricted Cash
-1.79.51.22-
Total Current Assets
271.9332.6298313.6274.6484.8
Property, Plant & Equipment
153.6163.4172.4180.6187.3125.3
Long-Term Investments
----54.859
Goodwill
47.151.6286.3287.4286.8239.2
Other Intangible Assets
131.8153.4262.4354.1386.8410.8
Other Long-Term Assets
4.85.68.510.88.41.6
Total Assets
609.2706.61,0281,1471,1991,321

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
27.63032.325.828.829.6
Accrued Expenses
71.371.386.575.770.282.7
Current Portion of Leases
7.86.912.816.214.113
Current Income Taxes Payable
6.35.75.14.64.84
Other Current Liabilities
24.619.927.433.619.375
Total Current Liabilities
137.6133.8164.1155.9137.2204.3
Long-Term Debt
121.1119.939.638.5--
Long-Term Leases
80.58387.997.4130.979.3
Long-Term Deferred Tax Liabilities
-----35.8
Other Long-Term Liabilities
11.934.971.544.833.5
Total Liabilities
340.2338.6326.5363.3312.9352.9

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10.90.90.90.80.8
Additional Paid-In Capital
1,5111,4891,4581,4161,2601,226
Retained Earnings
-1,244-1,123-756.8-629.5-366.2-254.2
Comprehensive Income & Other
0.70.8-0.8-3.7-8.9-5.1
Total Common Equity
269368701.1783.2885.8967.8
Shareholders' Equity
269368701.1783.2885.8967.8
Total Liabilities & Equity
609.2706.61,0281,1471,1991,321

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
209.4209.8140.3152.114592.3
Net Cash (Debt)
-102.3-60.2-37.9-11.224.7305.5
Net Cash Growth
-----91.92%-
Net Cash Per Share
-1.08-0.65-0.42-0.140.313.92
Filing Date Shares Outstanding
95.9293.5191.3189.8781.2280.02
Total Common Shares Outstanding
95.793.591.389.981.280
Working Capital
134.3198.8133.9157.7137.4280.5
Book Value Per Share
2.813.947.688.7110.9112.10
Tangible Book Value
90.1163152.4141.7212.2317.8
Tangible Book Value Per Share
0.941.741.671.582.613.97
Machinery
122.5121.5148.5147.6124.7112.4
Leasehold Improvements
78.680.478.591.367.938
SEC Filings: 10-K · 10-Q